跳至主要内容
临床试验/NCT04035317
NCT04035317撤回2 期

Effect of Aesculus Hippocastanum L. (Sapindaceae, "Horse Chestnut") on Fontan Circulation - a Randomized Clinical Trial

Casa Espirita Terra de Ismael1 个研究点 分布在 1 个国家开始时间: 2017年10月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
撤回
试验地点
1
主要终点
Mesenteric artery resistance

研究概览

简要总结

Patients after the Fontan operation at a single institution will be randomized to receive a standardized extract of Aesculus hippocastanum L. (horse chestnut) or placebo for 4 months in a crossover clinical trial. The primary outcome will be the mesenteric artery resistance measured by Dopple sonography.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

The capsules will be identical in appearance and will be labelled only with patient's name.

入排标准

年龄范围
2 Years 至 40 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Underwent Fontan surgery

排除标准

  • Severe adverse reaction
  • Personal or parental request

研究组 & 干预措施

Aesculus hippocastanum

Experimental

Patients will receive extract of Aesculus hippocastanum

干预措施: Aesculus Hippocastanum / Horse Chestnut (Drug)

Placebo

Placebo Comparator

Patients will receive placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Mesenteric artery resistance

时间窗: After 4 months

Mesenteric artery resistance, measured by pulsed-wave Doppler, in 0.1 units

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fabio Carmona

MD, PhD

Casa Espirita Terra de Ismael

研究点 (1)

Loading locations...

相似试验